Non-Viral Gene Delivery Methods

被引:3
作者
Wang, Weiwei [1 ,2 ,3 ]
Li, Wenzhong [1 ,2 ,3 ]
Ma, Nan [1 ,2 ,3 ]
Steinhoff, Gustav [1 ]
机构
[1] Univ Rostock, Dept Cardiac Surg, Reference & Translat Ctr Cardiac Stem Cell Therap, D-18057 Rostock, Germany
[2] Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, D-14513 Teltow, Germany
[3] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies BCRT, D-14513 Teltow, Germany
关键词
Non-viral gene delivery; gene therapy; physical gene delivery; chemical gene delivery; lipoplex; polyplex; transfection; LOW-MOLECULAR-WEIGHT; IN-VIVO ELECTROPORATION; LIPID-DNA COMPLEXES; HYDRODYNAMICS-BASED TRANSFECTION; BRAIN-BARRIER DISRUPTION; NAKED PLASMID DNA; CATIONIC LIPOSOMES; SKELETAL-MUSCLE; CELL-CYCLE; LIPOFECTION EFFICIENCY;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Gene delivery has attracted increasing interest as a highly promising therapeutic method to treat various diseases, including both genetic and acquired disorders. Viral-vectors based gene delivery can achieve higher transduction efficiency and long-term gene expression, but they may be associated with some shortcomings, such as immunogenicity, carcinogenicity, poor target cell specificity, inability to transfer large size genes and high costs. Non-viral approaches show high potential due to advantages of relative safety, ability to transfer large size gene, less toxicity and easiness for preparation etc. However, the clinical application of non-viral methods is still restricted by some limitations including low transfection efficiency and poor transgene expression. In order to improve gene transfer efficacy, a lot of efforts have been made in the past years, and numerous gene carriers and techniques have been developed. In this review, we summarized the features, drawbacks and prospects of existing and emerging non-viral gene delivery methods.
引用
收藏
页码:46 / 60
页数:15
相关论文
共 247 条
[1]   Biodegradable poly (ethylenimine) for plasmid DNA delivery [J].
Ahn, CH ;
Chae, SY ;
Bae, YH ;
Kim, SW .
JOURNAL OF CONTROLLED RELEASE, 2002, 80 (1-3) :273-282
[2]   Gene transfer into muscle by electroporation in vivo [J].
Aihara, H ;
Miyazaki, J .
NATURE BIOTECHNOLOGY, 1998, 16 (09) :867-870
[3]   Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis [J].
Akinc, A ;
Thomas, M ;
Klibanov, AM ;
Langer, R .
JOURNAL OF GENE MEDICINE, 2005, 7 (05) :657-663
[4]   Hydrodynamic Delivery [J].
Al-Dosari, Mohammed S. ;
Knapp, Joseph E. ;
Liu, Dexi .
NON-VIRAL VECTORS FOR GENE THERAPY, SECOND EDITION: PART 2, 2005, 54 :65-82
[5]   Nonviral Gene Delivery: Principle, Limitations, and Recent Progress [J].
Al-Dosari, Mohammed S. ;
Gao, Xiang .
AAPS JOURNAL, 2009, 11 (04) :671-681
[6]   Pig liver gene therapy by noninvasive interventionist catheterism [J].
Alino, S. F. ;
Herrero, M. J. ;
Noguera, I. ;
Dasi, F. ;
Sanchez, M. .
GENE THERAPY, 2007, 14 (04) :334-343
[7]   Lipoplex size determines lipofection efficiency with or without serum [J].
Almofti, MR ;
Harashima, H ;
Shinohara, Y ;
Almofti, A ;
Li, WH ;
Kiwada, H .
MOLECULAR MEMBRANE BIOLOGY, 2003, 20 (01) :35-43
[8]   DNA electrotransfer:: its principles and an updated review of its therapeutic applications [J].
André, F ;
Mir, LM .
GENE THERAPY, 2004, 11 (Suppl 1) :S33-S42
[9]   Ultrasound enhancement of cationic lipid-mediated gene transfer to primary tumors following systemic administration [J].
Anwer, K ;
Kao, G ;
Proctor, B ;
Anscombe, I ;
Florack, V ;
Earls, R ;
Wilson, E ;
McCreery, T ;
Unger, E ;
Rolland, A ;
Sullivan, SM .
GENE THERAPY, 2000, 7 (21) :1833-1839
[10]   Nucleofection-based ex vivo nonviral gene delivery to human stem cells as a platform for tissue regeneration [J].
Aslan, Hadi ;
Zilberman, Yoram ;
Arbeli, Vered ;
Sheyn, Dima ;
Matan, Yoav ;
Liebergall, Meir ;
Li, Jin Zhong ;
Helm, Gregory A. ;
Gazit, Dan ;
Gazit, Zulma .
TISSUE ENGINEERING, 2006, 12 (04) :877-889